| In Rs. Cr. | 202203 | 202303 | 202403 | 202503 | 202603 |
|---|---|---|---|---|---|
| Cash from Operating Activity+ | 91977.89 | 181330.17 | 2152.44 | 2413.38 | 3121.29 |
| Cash from Investing Activity | -136914.44 | -105412.87 | -2081.69 | -12682.95 | -196.42 |
| Cash from Financing Activity | 60462.06 | -73972.81 | 5.27 | 10232.56 | -2952.69 |
| Net Cash Flow | 15525.51 | 1944.49 | 76.02 | -37.01 | -27.82 |
| Opening Cash & Cash Equivalents | 12732.74 | 28306.04 | 304.82 | 382.01 | 403.88 |
| Closing Cash & Cash Equivalents | 28306.04 | 30482.07 | 382.01 | 403.88 | 391.69 |
| In Rs. Cr. | 2023-09 | 2023-12 | 2024-03 | 2024-06 |
|---|---|---|---|---|
| Net Sales | 2708.10 | 2606.96 | 2441.10 | 2893.42 |
| Expenditure+ | 2025.45 | 2000.45 | 1850.00 | 2211.66 |
| Other Income+ | 59.98 | 70.13 | 92.13 | 100.60 |
| Operating Profit | 682.65 | 606.51 | 591.10 | 681.76 |
| Interest | 8.62 | 9.18 | 9.38 | 10.91 |
| Depreciation and Amortization | 96.48 | 109.73 | 104.69 | 107.74 |
| Profit Before Tax | 640.99 | 562.33 | 571.58 | 667.62 |
| Tax+ | 129.81 | 102.52 | 94.98 | 124.55 |
| Net Profit | 511.18 | 459.81 | 476.59 | 543.07 |
No corporate actions available for this company
| In % | JUN'26 | MAR'26 | DEC'25 | SEP'25 | JUN'25 | MAR'25 | DEC'24 | SEP'24 | JUN'24 | MAR'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters+ | 72.63 | 72.66 | 72.66 | 72.67 | 72.68 | 72.70 | 72.71 | 74.87 | 74.87 | 74.88 |
| Public+ | 27.37 | 27.34 | 27.34 | 27.33 | 27.32 | 27.30 | 27.29 | 25.13 | 25.13 | 25.12 |
| Custodians | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Number of Shareholders | 166715 | 177606 | 177539 | 170347 | 179549 | 180597 | 171281 | 163854 | 153450 | 135116 |
Failed to load balance sheet data
Failed to load profit & loss data
Failed to load financial ratios
₹2469.9
- 107.05 (-4.15%)
04:01 pm - close price
BSE: MANKIND
NSE: MANKIND
Industry: Pharmaceuticals & Drugs
House: Private